Live from the NIH registry
Studies recruiting near Chandler right now
Top 25 of 1,372 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Cancer Treatment Centers of America-Phoenix — Phoenix, Arizona (17.2 mi)
· Sponsor: American Society of Clinical Oncology
Shared Decision Making to Improve Goals of Care in the ED
Goals
N/A
Interventional 230 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (15.9 mi)
· Sponsor: Mayo Clinic
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (17.2 mi)
· Sponsor: National Cancer Institute (NCI)
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 200 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (15.9 mi)
· Sponsor: Mayo Clinic
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
Banner MD Anderson Cancer Center — Gilbert, Arizona (6.0 mi)
· Sponsor: Allogene Therapeutics
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
KRAS G12C Mutation, KRAS G12S Mutation
Phase 1
Interventional 140 participants sought
Mayo Clinic, Phoenix — Phoenix, Arizona (17.2 mi)
· Sponsor: Kumquat Biosciences Inc.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Ironwood Cancer & Research Centers ( Site 0204) — Chandler, Arizona (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Phoenix — Phoenix, Arizona (17.2 mi)
· Sponsor: Tectonic Operating Company, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Research Network Arizona — Scottsdale, Arizona (15.9 mi)
· Sponsor: Boehringer Ingelheim
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
Banner MD Anderson Cancer Center ( Site 0001) — Gilbert, Arizona (6.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Arizona Gynecology Consultants — Phoenix, Arizona (17.2 mi)
· Sponsor: Rejoni Inc.
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
Digestive Health, Quality of Life
N/A
Interventional 114 participants sought
ASU Health Futures Center — Phoenix, Arizona (17.2 mi)
· Sponsor: Arizona State University
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
HonorHealth Scottsdale Shea Medical Center/HonorHealth Deer Valley Medical Center — Scottsdale, Arizona (15.9 mi)
· Sponsor: Magenta Medical Ltd.
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 40 participants sought
Medical Dermatology Specialists Phoenix — Phoenix, Arizona (17.2 mi)
· Sponsor: Incyte Corporation
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Colorectal Cancer, Colorectal Cancer (CRC)
Phase 1
Interventional 80 participants sought
Mayo Clinic Arizona — Phoenix, Arizona (17.2 mi)
· Sponsor: Cartography Biosciences
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Severe Tricuspid Regurgitation
N/A
Interventional 1,186 participants sought
Abrazo Arizona Heart Hospital — Phoenix, Arizona (17.2 mi)
· Sponsor: Medtronic Cardiovascular
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Chronic Low Back Pain
N/A
Interventional 2,529 participants sought
Phoenix VA Health Care System, Phoenix, AZ — Phoenix, Arizona (17.2 mi)
· Sponsor: VA Office of Research and Development
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Ironwood Cancer & Research Centers — Chandler, Arizona (1.7 mi)
· Sponsor: Guardant Health, Inc.
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Colorectal Carcinoma
N/A
Interventional 450 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (15.9 mi)
· Sponsor: Mayo Clinic
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Amyloid Plaque, Beta-Amyloid
Phase 1, Phase 2
Interventional 304 participants sought
Barrow Neurological Institute — Phoenix, Arizona (17.2 mi)
· Sponsor: AC Immune SA
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
HonorHealth — Scottsdale, Arizona (15.9 mi)
· Sponsor: Genentech, Inc.
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Phoenix, Arizona (17.2 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
HonorHealth — Scottsdale, Arizona (15.9 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Palo Verde Hematology Oncology — Glendale, Arizona (26.2 mi)
· Sponsor: Bristol-Myers Squibb
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0005 — Phoenix, Arizona (17.2 mi)
· Sponsor: Mirati Therapeutics Inc.